Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2017.12.009 (Original work published 2017)
. (2017).